Troriluzole for use in the treatment of spinocerebellar ataxia 3 (SCA3)

MD4483956T2Active Publication Date: 2026-06-30BIOHAVEN THERAPEUTICS LTD

View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office: MD · MD
Patent Type: Patents
Current Assignee / Owner: BIOHAVEN THERAPEUTICS LTD
Filing Date: 2018-11-11
Publication Date: 2026-06-30

Application Information

Patent Timeline

11 Nov 2018

Application

30 Jun 2026

Publication

MD4483956T2

IPC: A61K31/428; A61K9/20; A61K9/48; A61K31/427; A61K31/4985; A61K45/06; A61P25/14; A61P35/00; C07D277/82; C07D417/12

CPC: A61K31/428; C07D277/82; A61P35/00; A61K9/2063; A61K9/4858; A61K9/4866; A61K9/485; A61P25/14

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗

Get free access to AI patent search and analysis

Check patentability, review prior art and ask IP Agent with full patent context.

Patent Text Reader

Abstract

Methods of treating ataxia by administering to a patient in need thereof a prodrug of riluzole, such as troriluzole, are disclosed. Pharmaceutical compositions and kits comprising the prodrugs of riluzole are also disclosed.

Need to check novelty before this filing date? Find Prior Art